These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2995184)

  • 21. Insulin resistance in cirrhosis: evidence for a post-receptor defect.
    Proietto J; Nankervis A; Aitken P; Dudley FJ; Caruso G; Alford FP
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):677-88. PubMed ID: 6391747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity.
    Marangou AG; Weber KM; Boston RC; Aitken PM; Heggie JC; Kirsner RL; Best JD; Alford FP
    Diabetes; 1986 Dec; 35(12):1383-9. PubMed ID: 3533684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of insulin resistance in aging.
    Fink RI; Kolterman OG; Griffin J; Olefsky JM
    J Clin Invest; 1983 Jun; 71(6):1523-35. PubMed ID: 6345584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose stimulates insulin release without altering cyclic AMP production or inositolphospholipid turnover in freshly obtained human insulinoma cells.
    Chiba T; Yamatani T; Kadowaki S; Yamaguchi A; Inui T; Saito Y; Fujita T
    Biochem Biophys Res Commun; 1987 May; 145(1):263-8. PubMed ID: 2439077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to suppress C-peptide secretion by euglycaemic hyperinsulinaemia: a new diagnostic test for insulinoma?
    Yki-Järvinen H; Pelkonen R; Koivisto VA
    Clin Endocrinol (Oxf); 1985 Oct; 23(4):461-6. PubMed ID: 2998651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma.
    Sbraccia P; D'Adamo M; Leonetti F; Caiola S; Iozzo P; Giaccari A; Buongiorno A; Tamburrano G
    Diabetologia; 1996 Feb; 39(2):220-5. PubMed ID: 8635675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin and C-peptide in plasma and tumor of insulinoma patients.
    Ohneda A; Sakai T; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1983 Jan; 139(1):73-81. PubMed ID: 6301101
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
    Kolterman OG; Insel J; Saekow M; Olefsky JM
    J Clin Invest; 1980 Jun; 65(6):1272-84. PubMed ID: 6997333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin action and hepatic glucose cycling in Cushing's syndrome.
    Heaney AP; Harper R; Ennis C; Rooney DP; Sheridan B; Atkinson AB; Bell PM
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):735-43. PubMed ID: 9274705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin action during pregnancy. Studies with the euglycemic clamp technique.
    Ryan EA; O'Sullivan MJ; Skyler JS
    Diabetes; 1985 Apr; 34(4):380-9. PubMed ID: 3882502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and coronary artery disease.
    Bressler P; Bailey SR; Matsuda M; DeFronzo RA
    Diabetologia; 1996 Nov; 39(11):1345-50. PubMed ID: 8933003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
    Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
    J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-peptide suppression test for insulinoma.
    Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
    J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance in a case of coexisting insulinoma and type 2 diabetes.
    Grunberger G
    Acta Diabetol; 1993; 30(4):243-50. PubMed ID: 8180417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro study of cultured human insulinoma cells: evidence of abnormal sensitivity to glucose.
    Yasunami Y; Funakoshi A; Ono J; Miyazaki K; Jimi A; Konomi K
    J Clin Endocrinol Metab; 1987 Jul; 65(1):110-5. PubMed ID: 3034949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin binding to isolated monocytes and adipocytes in the study of hypoglycemic subjects and in the follow-up of patients with insulinoma.
    Pagano G; Trovati M; Cassader M; Bozzo C; Masciola P; Carta Q; Lorenzati R; Lenti G
    Diabete Metab; 1983 Mar; 9(1):14-8. PubMed ID: 6303874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes.
    Robert JJ; Magre J; Reynet C; Darmaun D; Picard J; Capeau J
    Diabete Metab; 1990; 16(3):240-7. PubMed ID: 2210020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.